Press Release

Article

Camber Pharmaceuticals Launches Generic Toviaz®

Camber Pharmaceuticals is excited to introduce Fesoterodine Fumarate Extended-Release Tablets.

Piscataway, NJ, April 17, 2024–Camber Pharmaceuticals is excited to introduce Fesoterodine Fumarate Extended-Release Tablets.

According to the Cleveland Clinic, approximately 33 million Americans struggle with overactive bladders, impacting about 30% of adult males and 40% of adult females nationwide.

Fesoterodine Fumarate ER Tablets are indicated for the treatment of overactive bladder (OAB) in adults with symptoms of urge urinary incontinence, urgency, and frequency.

Fesoterodine Fumarate ER Tablets are available in 30 count bottles in 4 mg and 8 mg strengths.

To learn more about Fesoterodine Fumarate Extended- Release Tablets, please visit https://www.camberpharma.com/products/fesoterodine-fumarate-er/

Camber Pharmaceuticals is a fully integrated pharmaceutical company. Its parent company, Hetero, of Hyderabad, India, is one of the world’s leading API and finished dose manufacturers. Camber is committed to bringing the highest quality generic pharmaceuticals to consumers and improving quality of life through cost-effective medications.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
1 expert in this video
1 expert in this video
1 expert in this video
1 expert in this video
Image credit:  Artur | stock.adobe.com
Cardiovascular disease doctor or cardiologist holding red heart in clinic or hospital exam room office for csr professional medical service, cardiology health care and world heart health day concept - Image credit: Chinnapong | stock.adobe.com